This report contains market size and forecasts of Genomic Testing in Cancer in Global, including the following market information:
Global Genomic Testing in Cancer Market Size 2023-2030, ($ millions)
The global Genomic Testing in Cancer market is projected to reach US$ million by 2030.
We surveyed the Genomic Testing in Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomic Testing in Cancer Market, by Type, 2023-2030 ($ millions)
Global Genomic Testing in Cancer Market Segment Percentages, by Type
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Global Genomic Testing in Cancer Market, by Application, 2023-2030 ($ millions)
Global Genomic Testing in Cancer Market Segment Percentages, by Application
General Hospitals
Specialty Clinics
Global Genomic Testing in Cancer Market, By Region and Country, 2023-2030 ($ Millions)
Global Genomic Testing in Cancer Market Segment Percentages, By Region and Country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
